Understanding access to gender-affirming treatments for transgender veterans
Understanding Perceived Access and Receipt of Gender-affirming Treatments Among Transgender Veterans
This study looks at how transgender veterans access gender-affirming treatments and what helps or hinders them in getting the care they need.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 700 (estimated) |
| Sex | All |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 1 site (Bedford, Massachusetts) |
| Trial ID | NCT06615401 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the experiences of transgender veterans regarding access to gender-affirming treatments (GATs) within the VA and VA Community Care. It will identify the types of GATs received, the barriers and facilitators affecting access, and how these factors influence the desire for GATs. By employing a mixed-methods approach, the study will gather qualitative and quantitative data to inform patient-centered strategies for improving GAT access. The findings will be used to develop implementation strategies in collaboration with a Stakeholder Advisory Group to enhance GAT delivery for transgender veterans.
Who should consider this trial
Good fit: Ideal candidates for this study are veterans who identify as transgender and have documentation of gender identity disorder diagnoses.
Not a fit: Patients who do not identify as transgender or do not have a diagnosis related to gender identity disorder may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved access to gender-affirming treatments for transgender veterans, enhancing their overall well-being.
How similar studies have performed: While this study addresses a significant gap in understanding GAT access for transgender veterans, similar studies have shown the importance of addressing barriers to care in LGBTQ+ populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All veterans with documentation of gender identity disorder diagnoses * Self-reported gender identity as transgender and relevant transgender-related health factor Exclusion Criteria: * None
Where this trial is running
Bedford, Massachusetts
- VA Bedford HealthCare System, Bedford, MA — Bedford, Massachusetts, United States (Recruiting)
Study contacts
- Principal investigator: Guneet K. Jasuja, PhD — VA Bedford HealthCare System, Bedford, MA
- Study coordinator: Guneet K Jasuja, PhD
- Email: Guneet.Jasuja@va.gov
- Phone: (781) 687-2767
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.